Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.740
-0.020 (-0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
2.750
+0.010 (0.36%)
After-hours: Mar 9, 2026, 4:04 PM EDT
Cellectar Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 12 | 13 | 12 | 34 | 16 | 41 | |
| Market Cap Growth | -24.56% | 1.37% | -63.75% | 112.09% | -60.44% | -57.05% | |
| Enterprise Value | -0 | 2 | -6 | 35 | -0 | 2 | |
| Last Close Price | 2.76 | 2.95 | 8.97 | 83.10 | 51.30 | 199.20 | |
| PB Ratio | 1.46 | 1.26 | 0.79 | -2.47 | 1.68 | 1.23 | |
| P/TBV Ratio | 1.55 | 1.56 | 0.90 | - | 1.97 | 1.28 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | -0.04 | 0.06 | 0.01 | |
| Net Debt / Equity Ratio | -1.29 | -1.29 | -1.45 | 0.65 | -2.02 | -1.07 | |
| Net Debt / EBITDA Ratio | 0.56 | 0.56 | 0.44 | 0.23 | 0.67 | 1.48 | |
| Net Debt / FCF Ratio | 0.55 | 0.55 | 0.48 | 0.27 | 0.76 | 1.56 | |
| Quick Ratio | 2.78 | 2.78 | 2.48 | 0.38 | 1.73 | 8.95 | |
| Current Ratio | 2.96 | 2.96 | 2.58 | 0.41 | 1.79 | 9.16 | |
| Return on Equity (ROE) | -170.27% | -170.27% | -4693.38% | - | -149.33% | -54.92% | |
| Return on Assets (ROA) | -71.01% | -71.01% | -172.36% | -144.66% | -61.26% | -31.47% | |
| Return on Capital Employed (ROCE) | -224.70% | -224.70% | -321.90% | 293.30% | -285.60% | -72.70% | |
| Earnings Yield | -175.70% | -174.21% | -361.29% | -125.65% | -198.10% | -59.46% | |
| FCF Yield | -186.45% | -184.87% | -386.45% | -97.66% | -158.57% | -55.98% | |
| Buyback Yield / Dilution | -110.67% | -110.67% | -203.92% | -73.22% | -27.09% | -180.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.